Navigation Links
China Sky One Medical, Inc. Acquires Drug to Treat Breast Lesions

HARBIN, China, Oct. 28 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that it recently reached an agreement to purchase a proprietary breast drug from Harbin Medical University for the treatment of lobular hyperplastic lesions of the breast.

Heilongjiang Tianlong Pharmaceutical Company, a subsidiary of China Sky One Medical, will purchase the breast drug for RMB 10 million (USD $1.46 million) from Harbin Medical University. The drug is intended to treat lobular hyperplasia in women, a type of mastitis that may lead to breast cancer. It is believed that lobular hyperplasia is brought about by stress, over work, and an irregular, high-pressure lifestyle. There are currently no drugs on the market dedicated to treating the disease, which is estimated to affect 36 million women in China.

China Sky One Medical collaborated with Harbin Medical University to develop the drug, which has been approved by the State Food and Drug Administration (SFDA) in China. First phase clinical trials have been completed. In over 10,000 trials, the drug has been shown to be 100% effective with an 89% curability rate. Following the completion of additional clinical trials, the Company expects to obtain production approval for the drug from the SFDA in two to three years following the purchase.

"We are very excited about the prospects for this drug, and estimate that it will generate RMB 1 billion (USD $146.2 million) within five years once production begins," said Mr. Yan-Qing Liu, Chairman, CEO and President of China Sky One Medical. By acquiring this drug from Harbin Medical University, we will further strengthen and diversify our product line and enhance future profitability."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR") and Harbin First Bio- Engineering Company Limited ("First"), the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

For more information, please contact:

Company Contact:

China Sky One Medical, Inc.

Mr. Yu-Bo Hao, Board Secretary

Tel: +86-0451-5399-4069


Investor Relations Contact:

Mr. Crocker Coulson, President

CCG Investor Relations

Tel: +1-646-213-1915



SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Simcere Pharmaceutical Group to Participate in Goldman Sachs China Investment Frontier Conference 2008
2. China Sky One Medical, Inc. Receives Tax Refund
3. Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair
4. iCRco Opens Regional Branch Office In Beijing, China
5. China Yingxia International, Inc. to Promote Benefits of Its Soy Milk Products Over Scandal-Stricken Cows Milk in China
6. China-Biotics, Inc. Sees No Impact on Its Business From Dairy Products Safety Concerns
7. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
8. China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger
9. China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
10. UNC School of Social Work helps China tackle growing pains
11. Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Advanced Hearing Solutions, Nashville ... annual Toast of Music City, a reader’s choice awards featuring favorite places to ... votes for their favorite businesses in over 200 categories, including best pizza, best ...
(Date:10/9/2015)... Stockholm, Sweden (PRWEB) , ... October 09, 2015 , ... ... 2015 Arnold Schwarzenegger World Jump Rope Championship in Madrid, Spain. Representing both the USA ... Speed Sprints, One-Minute Double Unders and One-Minute Am Front Crosses, she was awarded 1 ...
(Date:10/9/2015)... ... October 09, 2015 , ... "As a nurse, I ... from Philadelphia, Pa. "They have to wear large diapers or pads. We came up ... developed the TROUSAFE to absorb urine leaking from the tip of the penis. This ...
(Date:10/9/2015)... ... 09, 2015 , ... Santa Rosa Consulting and The University of Texas MD ... go-live on the Epic platform in March of 2016. Both entities have already begun ... the contract by supporting Scheduling Appointment Conversion and the Go-Live. , “We are ...
(Date:10/9/2015)... OR (PRWEB) , ... October 09, 2015 , ... Most ... less processed with more vegetables and less meat. While noted T’ai Chi Master and ... a “Yin and Yang” relationship between the two cuisines and that they potentially complement ...
Breaking Medicine News(10 mins):
... ... Systems, medical advisory committee in pain management, , ... Maywood NJ (PRWEB) October 13, 2009 -- Advanced Data Systems ... ,Dr. Venkataraman is a Managing Partner of Pain Centers of America, PA specializing in interventional ...
... ... Natural dry skin and eczema treatment, warns the public to continue protecting their skin from ... ... developed Skin MD Natural - a breakthrough in skin care technology recommended by thousands of ...
... ... of the NANDA International (NANDA-I) professional trade journal, International Journal of Nursing Terminologies and ... ... appointed as the new Editor of the NANDA International (NANDA-I) professional trade ...
... and physician named to lead new sports neurology division of ... 12 On the football field, the hockey rink or ... and a University of Michigan neurologist is leading the charge ... sports injuries. , Jeffrey S. Kutcher, M.D., a sports neurologist ...
... interviewing and cognitive behavioral skills training has been found ... to a pair of studies published online October 12 ... . Arthur V. Peterson, Ph.D., and colleagues ... colleagues designed the Hutchinson Study of High School Smoking ...
... Finding might yield insights into diseases like Parkinson,s, experts say ... specific genetic mutation seem to be "smarter," in the sense ... to make correct decisions quickly, a new German study suggests. ... in the prefrontal cortex of the brain, activity that is ...
Cached Medicine News:
(Date:10/9/2015)... , Oct. 9, 2015 Eli Lilly and ... 30,000 square feet and approximately 50 new jobs to its ... Science in New York, New York . ... in 2016, this space will include a translational immuno-oncology hub ... with opportunities for collaborative access to cutting-edge drug discovery capabilities, ...
(Date:10/9/2015)... , Schweiz, October 9, 2015 Der ... Dr.   Yutaka Kondo und Dr.   Junko Takita ...   2015 " geht an Dr.   Yutaka ... Der " JCA-Mauvernay Award   2015 ... Dr.   Junko Takita    ™ , das ...
(Date:10/8/2015)... PITTSBURGH , Oct. 8, 2015 /PRNewswire/ ... pharmaceutical company, will host a conference call and webcast ... ET to review the value to be created for ... TASE) through Mylan,s offer to acquire the company. During ... outlines the compelling proposition for Perrigo shareholders. Mylan,s offer ...
Breaking Medicine Technology:
... 27 ChemoCentryx, Inc., today announced that ... PROTECT-1 Study (the Prospective Randomized Oral Therapy ... (CCX282-B) in patients with moderate-to-severe Crohn,s disease. ... antagonist showed clinical efficacy in a 12-week ...
... NANJING, China, Oct. 27 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ... specializing in the development, manufacturing, and marketing of branded ... it will report its unaudited financial results for the ... 11, 2010, before the market opens in the United ...
Cached Medicine Technology:
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
... Distriman is a ... that is designed to ... used with Gilson DistriTip ... polypropylene syringes with level ...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
... Plus, a handheld manual dispenser, is ideal ... long series pipetting. Its increased volume selection ... research tasks, and its smooth handling reduces ... The nine Combitips allow a wider range ...
Medicine Products: